Trial
NCT04854499
Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Gilead Sciences
Collaborators
—
Condition
Head and Neck Squamous Cell Carcinoma
Intervention
Magrolimab
Why stopped
Sponsor decision to terminate study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-19